+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inotek Pharma - logo

Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts. It is focused on the development and commercialization of therapies for glaucoma and other serious diseases of the eye. The company's lead product candidate is Trabodenoson, formerly known as INO-8875, which is in Phase III clinical trials for lowering IOP. Trabodenoson has completed Phase 1, 2, and 3 clinical trials in subjects with OHT and POAG. Inotek was founded in 1999.

From
From
From
Open-Angle Glaucoma - Pipeline Insight, 2020 - Product Thumbnail Image

Open-Angle Glaucoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
From
From
Optic Neuropathy Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Optic Neuropathy Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • April 2018
  • 59 Pages
From
From
Adenosine A1 Receptor Antagonist -Pipeline Insight, 2019 - Product Thumbnail Image

Adenosine A1 Receptor Antagonist -Pipeline Insight, 2019

  • Drug Pipelines
  • January 2019
  • 60 Pages
From
Adenosine A1 Receptor Agonist -Pipeline Insight, 2019 - Product Thumbnail Image

Adenosine A1 Receptor Agonist -Pipeline Insight, 2019

  • Drug Pipelines
  • January 2019
  • 60 Pages
From
Adenosine A2A Receptor Agonist -Pipeline Insight, 2019 - Product Thumbnail Image

Adenosine A2A Receptor Agonist -Pipeline Insight, 2019

  • Drug Pipelines
  • January 2019
  • 60 Pages
From
Adenosine A3 Receptor Agonist -Pipeline Insight, 2019 - Product Thumbnail Image

Adenosine A3 Receptor Agonist -Pipeline Insight, 2019

  • Drug Pipelines
  • January 2019
  • 60 Pages
From
From
Retinal Degeneration Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Retinal Degeneration Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • July 2018
  • 73 Pages
From
Loading Indicator
adroll